Aptevo Therapeutics (APVO) Tops Q1 EPS by 161c
Get Alerts APVO Hot Sheet
Join SI Premium – FREE
Aptevo Therapeutics (NASDAQ: APVO) reported Q1 EPS of $0.26, $1.61 better than the analyst estimate of ($1.35).
For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Citi cuts Weibo stock rating to Neutral, lowers price target
- ACRES Commercial Realty says labor dispute is hindering hotel sale
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share